News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
691,715 Results
Type
Article (39621)
Company Profile (248)
Press Release (651846)
Section
Business (204153)
Career Advice (2003)
Deals (35421)
Drug Delivery (89)
Drug Development (81115)
Employer Resources (169)
FDA (16140)
Job Trends (14825)
News (345210)
Policy (32506)
Tag
Academia (2537)
Alliances (49379)
Alzheimer's disease (1299)
Approvals (16105)
Artificial intelligence (179)
Bankruptcy (354)
Best Places to Work (11623)
Biotechnology (175)
Breast cancer (215)
Cancer (1599)
Cardiovascular disease (122)
Career advice (1668)
CAR-T (112)
Cell therapy (323)
Clinical research (65174)
Collaboration (606)
Compensation (313)
COVID-19 (2555)
C-suite (141)
Data (1510)
Diabetes (194)
Diagnostics (6235)
Earnings (85155)
Employer resources (146)
Events (110609)
Executive appointments (516)
FDA (16956)
Funding (548)
Gene therapy (223)
GLP-1 (633)
Government (4352)
Healthcare (18764)
Infectious disease (2653)
Inflammatory bowel disease (115)
Interviews (309)
IPO (16432)
Job creations (3629)
Job search strategy (1420)
Layoffs (431)
Legal (7882)
Lung cancer (239)
Manufacturing (223)
Medical device (13244)
Medtech (13249)
Mergers & acquisitions (19295)
Metabolic disorders (513)
Neuroscience (1677)
NextGen: Class of 2025 (6509)
Non-profit (4473)
Northern California (1921)
Obesity (293)
Opinion (188)
Patents (138)
People (56747)
Phase I (20319)
Phase II (28696)
Phase III (21363)
Pipeline (638)
Postmarket research (2570)
Preclinical (8613)
Radiopharmaceuticals (241)
Rare diseases (299)
Real estate (5901)
Regulatory (21869)
Research institute (2317)
Resumes & cover letters (349)
Southern California (1663)
Startups (3576)
United States (17213)
Vaccines (589)
Weight loss (200)
Date
Last 7 days (621)
Last 30 days (2578)
Last 365 days (34669)
2025 (2650)
2024 (35245)
2023 (40099)
2022 (51216)
2021 (55765)
2020 (54126)
2019 (46583)
2018 (35043)
2017 (32147)
2016 (31510)
2015 (37588)
2014 (31361)
2013 (26389)
2012 (28624)
2011 (29312)
2010 (27386)
Location
Africa (713)
Arizona (206)
Asia (37611)
Australia (6178)
California (4398)
Canada (1603)
China (370)
Colorado (198)
Connecticut (210)
Europe (80485)
Florida (633)
Georgia (154)
Illinois (432)
Indiana (249)
Maryland (697)
Massachusetts (3389)
Michigan (188)
Minnesota (321)
New Jersey (1244)
New York (1268)
North Carolina (798)
Northern California (1921)
Ohio (161)
Pennsylvania (1026)
South America (1094)
Southern California (1663)
Texas (643)
Utah (129)
Washington State (435)
691,715 Results for "anticancer inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Beach
AntiCancer Inc. Has Received a New Patent That Revolutionizes Individualized Mouse Models of Human Cancer Patients by Increasing the Patient-tumor Establishment Rate in Mice to Close to 100%
AntiCancer Inc. announced it has just received US Patent 11,871,731 that describes a method to increase the rate of establishment of patient tumors in mice to close to 100%.
January 29, 2024
·
1 min read
Press Releases
ME Therapeutics Announces That Its First Therapeutic mRNA Candidate Shows Encouraging Anti-Cancer Efficacy in Vivo
January 14, 2025
·
3 min read
Defence’s AccuTOX Published in the Prestigious Journal of Translational Medicine Its Peer Study with Preclinical Data on AccuTOX as an Anti-Cancer Molecule
Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) (“Defence” or the “Company”), a Canadian biopharmaceutical company developing novel immune-oncology vaccines and drug delivery technologies, is please to announce the publication of a peer-reviewed study on the anticancer properties of its unconjugated AccuTOX®, one of Defence’s lead products engineered to treat established solid tumors.
June 6, 2024
·
6 min read
Defence’s ARM-X Anti-Cancer Vaccine Inhibits Growth of Pre-Established Ovarian Cancer Resulting in Complete Responses in Treated Animals
Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) (“Defence” or the “Company”), a Canadian biopharmaceutical company developing novel immune-oncology vaccines and drug delivery technologies, is pleased to announce that its second-generation ARM-X anti-cancer vaccine is therapeutically effective against pre-established ovarian cancer (ID8 model) when combined with the anti-PD-1 immune-checkpoint inhibitor.
June 25, 2024
·
4 min read
Press Releases
BeyondSpring Announces $35.4 Million Sale of a Portion of Equity Interest in SEED Therapeutics to Advance Lead Asset Plinabulin to Anti-Cancer Registrational Studies
January 28, 2025
·
10 min read
Can-Fite: Breakthrough Findings Demonstrate Namodenoson Anti-cancer and Protective Effect Mechanism in the Liver
Can-Fite BioPharma Ltd., a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological and inflammatory diseases, announces that company scientists came up with breakthrough findings showing that the anti-cancer and protective effects in the liver are conferred via the signalling protein adiponectin.
June 24, 2024
·
6 min read
Defence Announces Peer-Reviewed Publication on Accum-E7 Anti-Cancer Vaccine in Cancer Science Journal and Financing Update
Defence Therapeutics Inc. is pleased to announce the publication of a peer-reviewed study on the anticancer properties of its dual Accum®-E7 vaccine, one of Defence’s experimental product designed to treat established cervical cancer.
March 1, 2024
·
5 min read
Press Releases
Recognition of the American Society of Clinical Oncology (ASCO) of the Liver Protective Effect of Can-Fite’s anti-Cancer Drug Namodenoson
December 31, 2024
·
6 min read
Pharm Country
Anti-Cancer Drugs Publishes Preclinical Data Demonstrating the Broad Antineoplastic Activity of Panavance’s Misetionamide (GP-2250)
Panavance Therapeutics Inc. today announced publication of positive data in the peer-reviewed Anti-Cancer Drugs in an article titled, “Antineoplastic Activity of GP-2250 In Vitro and in Mouse Xenograft Models.”
February 1, 2024
·
5 min read
Business
Aktis Oncology Enters Into Strategic Collaboration With Lilly to Discover and Develop Novel Anticancer Radiopharmaceuticals
Aktis Oncology, a biotechnology company discovering and developing novel targeted radiopharmaceuticals to treat a broad range of solid tumors, announced a multi-target discovery collaboration agreement with Eli Lilly and Company to generate anticancer radiopharmaceuticals using Aktis Oncology’s novel miniprotein technology platform.
May 21, 2024
·
3 min read
1 of 69,172
Next
